Impact of obstructive sleep apnoea (OSA) on glucose metabolism

I. Harsch (Erlangen, Germany)

Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Disease area: Sleep and breathing disorders

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Harsch (Erlangen, Germany). Impact of obstructive sleep apnoea (OSA) on glucose metabolism. Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007


Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019


Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002

Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Obesity, obstructive sleep apnea (OSA) and asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Effect of smoking on obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011



Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004

Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Source: Eur Respir Rev 2007; 16: 196-202
Year: 2007



Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome
Source: Eur Respir J 2003; 22: 156-160
Year: 2003



Hyperuricaemia in males with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Hyperuricaemia in females with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2003; 22: Suppl. 45, 91s
Year: 2003

Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Sleep, sleep-disordered breathing and metabolic consequences
Source: Eur Respir J 2009; 34: 243-260
Year: 2009



Effects of a 30º and 60º sleep position on sleep quality, snoring and apnoea/hypopnoea (AHI) index in patients with mild obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 642s
Year: 2006